AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE BEHAVIORAL HEALTH CONSORTIUM AND THE PRESCRIPTION OPIOID DISTRIBUTION COMMISSION.
Sponsored By: Melissa Minor-Brown (Democratic)
Signed by Governor
Your PRIA Score
Personalized for You
How does this bill affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Rules to use and report opioid funds
The Commission must use Settlement and Impact Fund money only to fight the opioid crisis and must follow settlement or bankruptcy terms. It can award grants, direct the health department to sign contracts, or send money to agencies and local governments with instructions. The State Treasurer pays out money only after a special form is signed by the Commission chair, the OMB Director, the Controller General, and the Joint Finance Committee co-chairs. The OMB Director may waive certain Chapter 69 rules to help the Commission make distributions. Beginning January 1, 2022, the Commission posts a yearly report online listing all amounts received, grants, contracts, and disbursements, and sends copies to the Consortium, Legislative Services, and the Public Archives.
Opioid funds board with public input
The law creates the Prescription Opioid Settlement Distribution Commission under the Consortium. The Governor, or a designee, chairs the Commission, and members may elect a vice chair. A quorum is a majority of current members, and votes happen at public meetings. The chair can create committees and include non-members. Before spending, the Commission must seek stakeholder consensus and give Delawareans a chance to share input. The Commission must approve all payments from the Settlement and Impact funds.
Stronger statewide behavioral health oversight
The law creates a statewide Behavioral Health Consortium to oversee behavioral health and substance use care. The Consortium has 25 members. Appointed members serve 2-year terms and can serve up to 3 terms, or 6 years total. Shorter first terms are allowed to stagger end dates. The Consortium must report recommendations to the Governor and General Assembly. The first report was due April 16, 2018.
Sponsors & Cosponsors
Sponsor
Melissa Minor-Brown
Democratic • House
Cosponsors
Frank Burns
Democratic • House
Kendra Johnson
Democratic • House
Michael F. Smith
Republican • House
DeShanna U Neal
Democratic • House
Ray Seigfried
Democratic • Senate
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
HS 1 for HB 169 - Signed by Governor
8/25/2025GovernorHS 1 for HB 169 - Passed By Senate. Votes: 21 YES
6/26/2025SenateHS 1 for HB 169 - Reported Out of Committee (Health & Social Services) in Senate with 1 Favorable, 4 On Its Merits
6/25/2025SenateHS 1 for HB 169 - Assigned to Health & Social Services Committee in Senate
6/12/2025SenateHS 1 for HB 169 - Passed By House. Votes: 40 YES 1 ABSENT
6/12/2025HouseSubstituted in House by HS 1 for HB 169
6/11/2025HouseAmendment HA 1 to HB 169 - Introduced and Placed With Bill
6/5/2025HouseReported Out of Committee (Health & Human Development) in House with 3 Favorable, 11 On Its Merits
5/21/2025HouseIntroduced and Assigned to Health & Human Development Committee in House
5/15/2025House
Bill Text
Current
5/15/2025
Related Bills
SB 110 — AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO THE EXAMINING BOARD OF PHYSICAL THERAPISTS AND ATHLETIC TRAINERS.
HB 221 — AN ACT TO AMEND TITLE 3 OF THE DELAWARE CODE RELATING TO PESTICIDES.
HB 191 — AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO MEDICAL PROFESSIONALS, TITLES, AND NONHUMAN ENTITIES.
HB 266 w/ SA 1 — AN ACT TO AMEND TITLE 21 OF THE DELAWARE CODE RELATING TO MOTORIZED SCOOTERS.
HB 231 — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO UNIFORM HEALTH DATA.
SB 191 — AN ACT TO AMEND TITLE 16 OF THE DELAWARE CODE RELATING TO THE DELAWARE INSTITUTE FOR DENTAL EDUCATION AND RESEARCH.